MSMR. 2020 Mar;27(3):19-23.
The EpiData Center (EDC) has provided routine blood lead level (BLL) surveillance for Department of Defense (DoD) pediatric beneficiaries since 2011. Data for this study were collected and compiled from raw laboratory test records obtained from the Composite Health Care System Health Level 7 (HL7)-formatted chemistry data, allowing an overview of the number of tests performed and the number of elevated results. Between 2010 and 2017, there were 177,061 tests performed among 162,238 pediatric beneficiaries tested. Using only the highest test result per year for each individual, 169,917 tests were retained for analysis, of which 1,334 (0.79%) test results were considered elevated. The percentage of children with elevated BLLs generally decreased over the time period for children of every service affiliation. All tests throughout this time frame were evaluated using current standards and the protocol followed by the Centers for Disease Control and Prevention and the Department of the Navy (DON). The adoption of a standardized BLL surveillance methodology across the DoD supports a cohesive approach to an evolving public health surveillance topic.
EpiData 中心（EDC）自 2011 年以来一直为国防部（DoD）儿科受益人群提供常规血铅水平（BLL）监测。本研究的数据是从综合保健系统健康水平 7（HL7）格式的化学数据中获得的原始实验室测试记录中收集和编制的，允许概述测试的数量和升高结果的数量。在 2010 年至 2017 年期间，对 162238 名接受测试的儿科受益人群进行了 177061 次测试。仅使用每个人每年的最高测试结果，保留了 169917 次测试进行分析，其中 1334 次（0.79%）测试结果被认为升高。在每个服务隶属关系的儿童中，血铅升高儿童的百分比总体呈下降趋势。在此期间的所有测试均使用当前标准和疾病控制与预防中心以及海军部（DON）遵循的方案进行了评估。在整个国防部采用标准化 BLL 监测方法支持了对不断发展的公共卫生监测主题的一致方法。
